A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy

Brain

Volumn 123, Issue 4, 2000, Pages 724-732

  Halliday, G M ^a   Hardman, C D ^a   Cordato, N J ^a,b   Hely, M A ^b   Morris, J G L ^b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Gaze palsy; Globus pallidus; Neuronal cell loss; Substantia nigra; Subthalamic nucleus

Indexed keywords

AGED; ARTICLE; BASAL GANGLION; CELL COUNT; CELL LOSS; CLINICAL ARTICLE; FEMALE; GAZE PARALYSIS; GLOBUS PALLIDUS; HUMAN; MALE; NERVE CELL; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SUBSTANTIA NIGRA; SUPERIOR COLLICULUS;

EID: 0034105980     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.4.724     Document Type: Article

References (46)

1. Agid Y, Javoy-Agid F, Ruberg M, Pillon B, Dubois B, Duyckaerts C, et al. Progressive supranuclear palsy: anatomoclinical and biochemical considerations. Adv Neurol 1987; 45: 191-206.
2. Bevan MD, Francis CM, Bolam JP. The glutamate-enriched cortical and thalamic input to neurons in the subthalamic nucleus of the rat: convergence with GABA-positive terminals. J Comp Neurol 1995; 361: 491-511.
3. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997; 49: 1284-8.
4. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. [Review]. Acta Neuropathol (Berl) 1991; 82: 239-59.
5. Braak H, Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. [Review], J Neural Transm 1998; Suppl 53: 127-40.
6. Büttner-Ennever JA, Horn AK. Anatomical substrates of oculomotor control. [Review]. Curr Opin Neurobiol 1997; 7: 872-9.
7. Chin SS, Goldman JE. Glial inclusions in CNS degenerative diseases. [Review]. J Neuropathol Exp Neurol 1996; 55: 499-508.
8. Daniel SE, de Bruin VM, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. [Review]. Brain 1995; 118: 759-70.
9. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995; 146: 1388-96.
10. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996; 55: 53-67.
11. Francois C, Percheron G, Yelnik J. Localization of nigrostriatal, nigrothalamic and nigrotectal neurons in ventricular coordinates in macaques. Neuroscience 1984; 13: 61-76.
12. Gearing M, Olson DA, Watts RL, Mirra SS. Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 1994; 44: 1015-24.
13. Golbe LI. The epidemiology of PSP. [Review]. J Neural Transm 1994; Suppl 42: 263-73.
14. Goldberg ME, Eggers HM, Gouras P. The ocular motor system. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neural science, 3rd ed. New York: Elsevier; 1991. p. 660-78.
15. Halliday GM, Davies L, McRitchie DA, Cartwright H, Pamphlett R, Morris JG. Ubiquitin-positive achromatic neurons in corticobasal degeneration. Acta Neuropathol (Berl) 1995; 90: 68-75.
16. Hardman CD, Halliday GM. The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy. Mov Disord 1999a; 14: 626-33.
17. Hardman CD, Halliday GM. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease. Exp Neurol 1999b; 158: 135-42.
18. Hardman CD, McRitchie DA, Halliday GM, Cartwright HR, Morris JG. Substantia nigra pars reticulata neurons in Parkinson's disease. Neurodegeneration 1996; 5: 49-55.
19. Hardman CD, Halliday GM, McRitchie DA, Cartwright HR, Morris JG. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata. Exp Neurol 1997a; 144: 183-92.
20. Hardman CD, Halliday GM, McRitchie DA, Morris JG. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J Neuropathol Exp Neurol 1997b; 56: 132-12.
21. Hauw J-J, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). [Review]. Neurology 1994; 44: 2015-9.
22. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-72.
23. Ikeda K, Akiyama H, Arai T, Nishimura T. Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles. Neurobiol Aging 1998; 19 (1 Suppl): S85-91.
24. Juncos JL, Hirsch EC, Malessa S, Duyckaerts C, Hersh LB, Agid Y. Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology 1991; 41: 25-30.
25. Kawagoe R, Takikawa Y, Hikosaka O. Expectation of reward modulates cognitive signals in the basal ganglia. Nat Neurosci 1998; 1: 411-6.
26. Künzle H, Akert K. Efferent connections of cortical, area 8 (frontal eye field) in Macaca fascicularis. A reinvestigation using the autoradiographic technique. J Comp Neurol 1977; 173: 147-64.
27. Lantos PL. The neuropathology of progressive supranuclear palsy. [Review]. J Neural Transm 1994; Suppl 42: 137-52.
28. Litvan I. Progressive supranuclear palsy revisited. [Review]. Acta Neurol Scand 1998; 98: 73-84.
29. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996a; 55: 97-105.
30. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996b; 60: 615-20.
31. Luna B, Thulborn KR, Strojwas MH, McCurtain BJ, Berman RA, Genovese CR, et al. Dorsal cortical regions subserving visually guided saccades in humans: an fMRI study. Cereb Cortex 1998; 8: 40-7.
32. Malessa S, Hirsch EC, Cervera P, Javoy-Agid F, Duyckaerts C, Hauw JJ, et al. Progressive supranuclear palsy: loss of cholineacetyltransferase-like immunoreactive neurons in the pontine reticular formation. Neurology 1991; 41: 1593-7.
33. Malessa S, Gaymard B, Rivaud S, Cervera P, Hirsch E, Verny M, et al. Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study. Neurology 1994; 44: 716-21.
34. McRitchie DA, Halliday GM, Cartwright H. Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human. Neuroscience 1995; 68: 539-51.
35. McRitchie DA, Hardman CD, Halliday GM. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol 1996; 364: 121-50.
36. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86.
37. Nambu A, Takada M, Inase M, Tokuno H. Dual somatotopical representations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and supplementary motor area. J Neurosci 1996; 16: 2671-83.
38. Noda T, Oka H. Projections of the anterior coronal gyrus to the subthalamic nucleus in the cat: a combined retrograde and anterograde WGA-HRP study. Brain Res 1993; 605: 305-8.
39. Parent A, Hazrati L-N. Functional anatomy of the basal ganglia. II. The place of the subthalamic nucleus and external pallidum in basal ganglia circuitry. [Review]. Brain Res Brain Res Rev 1995; 20: 128-54.
40. Probst A, Langui D, Lautenschlager C, Ulrich J, Brion JP, Anderton BH. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Acta Neuropathol (Berl) 1988; 77: 61-8.
41. Revesz T, Sangha H, Daniel SE. The nucleus raphe interpositus in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Brain 1996; 119: 1137-43.
42. Santacruz P, Uttl B, Litvan I, Grafman J. Progressive supranuclear palsy. A survey of the disease course. Neurology 1998; 50: 1637-47.
43. Sharpe JA. Cortical control of eye movements. [Review]. Curr Opin Neurol 1998; 11: 31-8.
44. Stell R, Bronstein AM. Eye movement abnormalities in extrapyramidal diseases. In: Marsden CD, Fahn S, editors. Movement disorders 3. Oxford: Butterworth-Heinemann; 1994. p. 88-113.
45. Tokuno H, Takada M, Kondo Y, Mizuno N. Laminar organization of the substantia nigra pars reticulata in the macaque monkey, with special reference to the caudato-nigro-tectal link. Exp Brain Res 1993; 92: 545-8.
46. Verny M, Duyckaerts C, Agid Y, Hauw J-J. The significance of cortical pathology in progressive supranuclear palsy. Clinicopathological data in 10 cases. Brain 1996; 119: 1123-36.